This trial is testing a new intervention for reducing screen time in overweight or obese adults. The intervention has three components and will be tested over 16 weeks.
1 Primary · 4 Secondary · Reporting Duration: Baseline, 8 weeks, 16 weeks
Active Control
Experimental Treatment
240 Total Participants · 8 Treatment Groups
Primary Treatment: Sedentary Screen Time lockout: LOCKOUT · No Placebo Group · N/A
Age 23 - 64 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: